Oxford University have paused an ongoing pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca.In an official statement, the university said that it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA), as reported by the Hill.An Oxford spokesperson said "there are no safety concerns concerning the pediatric research, but the trial is paused while they await additional information from MHRA," "which is reviewing possible links between the vaccine and rare blood clots in adults," the spokesperson added.The trial is testing the effectiveness of the vaccine in up to 300 children between the ages of 6 and 17."Whilst there are no safety.